Ibaraki, Japan

Kazumi Kikuchi

This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazumi Kikuchi. Retrieved from https://idiyas.com/inventor/kazumi-kikuchi-nba6mg39

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazumi Kikuchi: Innovator in Pharmaceutical Chemistry

Introduction

Kazumi Kikuchi is a notable inventor based in Ibaraki, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on pyrazolotriazole derivatives. Her research has the potential to impact various therapeutic areas.

Latest Patents

Kazumi Kikuchi holds one patent related to pyrazolotriazole derivatives. This patent showcases her expertise and dedication to advancing pharmaceutical science.

Career Highlights

Kikuchi is currently employed at Yamanouchi Pharmaceutical Company Ltd., where she continues to develop her research and contribute to the company's innovative projects. Her work at Yamanouchi has positioned her as a key player in the pharmaceutical industry.

Collaborations

Throughout her career, Kazumi has collaborated with esteemed colleagues, including Toshio Okazaki and Akira Suga. These collaborations have enriched her research and expanded the scope of her work.

Conclusion

Kazumi Kikuchi is a pioneering inventor whose contributions to pharmaceutical chemistry are noteworthy. Her patent on pyrazolotriazole derivatives exemplifies her commitment to innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…